483
Maquet Cardiopulmonary GmbHMaquet Cardiopulmonary GmbH – FDA 483, Jun 24, 2022
Record Details
An FDA inspection of Maquet Cardiopulmonary GmbH in Hechingen, Germany, revealed significant deficiencies across multiple quality system areas. The firm failed to adequately establish and implement procedures for corrective and preventive actions, design validation, risk analysis, design review, and process validation. These issues are particularly severe as the firm was previously issued a 483 in 2013 for similar deficiencies, leading to a Consent Decree in 2015.
View Company Profile
ID · 72c6f95d-aeab-43b9-afab-c2e7a15ecb9c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.